Provided by Tiger Fintech (Singapore) Pte. Ltd.

DOGWOOD THERAPEUTICS INC

5.37
+1.1025.76%
Post-market: 5.24-0.1300-2.42%19:06 EDT
Volume:21.18M
Turnover:134.15M
Market Cap:10.26M
PE:-0.43
High:7.73
Open:5.41
Low:5.21
Close:4.27
Loading ...

Dogwood Therapeutics Inc expected to post a loss of $1.41 a share - Earnings Preview

Reuters
·
24 Feb

DWTX Stock trading resumes

TIPRANKS
·
12 Feb

DWTX Stock trading halted, volatility trading pause

TIPRANKS
·
12 Feb

4 Stocks to Buy on Trump’s Turbocharged News Cycle

InvestorPlace
·
10 Feb

DWTX Stock trading resumes

TIPRANKS
·
27 Jan

DWTX Stock trading halted, volatility trading pause

TIPRANKS
·
27 Jan

Dogwood announces first patient dosed in Phase 2b trial on Halneuron

TIPRANKS
·
21 Jan

Dogwood Therapeutics Announces Patient Dosing in Phase 2B Trial Evaluating Halneuron® in Patients With Chemotherapy Induced Neuropathy (Cinp) to Commence First Quarter of 2025

THOMSON REUTERS
·
21 Jan

Dogwood Therapeutics Inc - Interim Data From Phase 2 Cinp Study Expected in 2H 2025

THOMSON REUTERS
·
21 Jan

Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break

MT Newswires Live
·
24 Dec 2024

BRIEF-Dogwood Therapeutics Announces Low Dose IMC-2 Treatment

Reuters
·
18 Nov 2024

Dogwood says low-dose IMC-2 treatment reduces long-COVID fatigue

TIPRANKS
·
18 Nov 2024

Dogwood Therapeutics, Inc. Announces Low Dose Imc-2 Treatment Reduces Long-Covid Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

THOMSON REUTERS
·
18 Nov 2024

Dogwood Therapeutics Inc - Imc-2 Shows Robust Reduction in Fatigue

THOMSON REUTERS
·
18 Nov 2024

DWTX: Phase 2 Long COVID Results Expected Soon

Zacks Small Cap Research
·
11 Nov 2024

Dogwood Therapeutics Faces Potential Asset Loss and Financial Risks Amid Sealbond Repurchase Option

TIPRANKS
·
09 Nov 2024

Q3 2024 Dogwood Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
08 Nov 2024

Dogwood Therapeutics Inc (DWTX) Q3 2024 Earnings Call Highlights: Strategic Financing and ...

GuruFocus.com
·
08 Nov 2024

BRIEF-Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

Reuters
·
07 Nov 2024

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

THOMSON REUTERS
·
07 Nov 2024